Rankings
▼
Calendar
EWTX FY 2019 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$123,000
Operating Income
-$10M
Net Income
-$9M
EPS (Diluted)
$-0.19
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$77,000
Balance Sheet
Total Assets
$25M
Total Liabilities
$41M
Stockholders' Equity
-$17M
Cash & Equivalents
$24M
← Q1 2020
All Quarters
